Apolipoprotein E represents a potent gene‐based therapeutic target for the treatment of sporadic Alzheimer's disease-Reference-Cited by-同舟云学术

Apolipoprotein E represents a potent gene‐based therapeutic target for the treatment of sporadic Alzheimer's disease

Published:2008-01 Issue:1S1 Volume:4 Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Poirier Judes¹

Affiliation:

1. McGill Centre for Studies in Aging and Douglas Mental Health University InstituteMontrealQuebecCanada

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2007.11.012

Reference50 articles.

1. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions

2. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

3. Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease;Beffert U.;Neurobiol Alzheimers Dis,1996

4. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.

5. Plastic Neuronal Remodeling Is Impaired in Patients with Alzheimer’s Disease Carrying Apolipoprotein ε4 Allele

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives;IBRO Neuroscience Reports;2024-06

2. HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer’s Disease Pathogenesis;International Journal of Molecular Sciences;2022-08-19

3. The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease;Psychiatry and Neuroscience Update;2021

4. Cholesterol and Dementia: A Long and Complicated Relationship;Current Aging Science;2020-04-25

5. Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease;The Journal of Neuroscience;2020-01-08